CVX
25
14
SJM
17
5
NWSA
69
4
EQR
33
6
NTRS
35
10
EXPE
83
8
KO
44
2
DNB
72
4
LB
16
9
FOX
71
3
HPE
48
2
HUM
25
4
INTC
35
4
NEM
30
2
VRSK
54
2
CI
35
2
UAL
73
3
EQIX
59
2
CMCSA
49
3
DFS
64
4
CVX
25
14
SJM
17
5
NWSA
69
4
EQR
33
6
NTRS
35
10
EXPE
83
8
KO
44
2
DNB
72
4
LB
16
9
FOX
71
3
HPE
48
2
HUM
25
4
INTC
35
4
NEM
30
2
VRSK
54
2
CI
35
2
UAL
73
3
EQIX
59
2
CMCSA
49
3
DFS
64
4
Financhill
Back

Blueprint Medicines Vs. Biomarin Pharmaceutical Industry Stock Comparison

Sell
40

BPMC
Blueprint Medicines

Last Price:
$90.24
Seasonality Move:
2.18%
Buy
60

BMRN
Biomarin Pharmaceutical

Last Price:
$65.65
Seasonality Move:
5.39%
Sell
40
Blueprint Medicines (BPMC) is a Sell

Is Blueprint Medicines a Buy, Sell or Hold?

  • The current Blueprint Medicines [BPMC] share price is $90.19. The Score for BPMC is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
  • BPMC is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
60
Biomarin Pharmaceutical (BMRN) is a Buy

Is Biomarin Pharmaceutical a Buy, Sell or Hold?

  • The current Biomarin Pharmaceutical [BMRN] share price is $65.69. The Score for BMRN is 60, which is 20% above its historic median score of 50, and infers lower risk than normal.
  • BMRN is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

BPMC Stock Price Chart

What is Blueprint Medicines's stock price today?

  • The Blueprint Medicines share price today is $90.19
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BPMC is experiencing slight buying pressure.

BMRN Stock Price Chart

What is Biomarin Pharmaceutical's stock price today?

  • The Biomarin Pharmaceutical share price today is $65.69
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BMRN is experiencing slight buying pressure.

BPMC Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.52 Sell
Relative Strength Index (14 RSI): 42.23 Sell
Chaikin Money Flow: 540770 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (91.73 - 96.57) Sell
Bollinger Bands (100): (87.46 - 96.54) Sell

BMRN Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.22 Sell
Relative Strength Index (14 RSI): 48.8 Sell
Chaikin Money Flow: 1709604 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (63.56 - 66.54) Buy
Bollinger Bands (100): (64.13 - 84.07) Sell

BPMC Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 92.88 Sell
20-day SMA: 94.44 Sell
50-day SMA: 92.37 Sell
200-day SMA: 96.72 Sell
8-day EMA: 92.45 Sell
20-day EMA: 93.6 Sell
50-day EMA: 93.36 Sell
200-day EMA: 91.74 Sell

BMRN Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 65.79 Sell
20-day SMA: 65.64 Buy
50-day SMA: 66.69 Sell
200-day SMA: 78.92 Sell
8-day EMA: 65.67 Buy
20-day EMA: 65.74 Sell
50-day EMA: 67.62 Sell
200-day EMA: 77.02 Sell

Blueprint Medicines Earnings Growth & BPMC Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.73 per share, a decrease next quarter of $0.00 per share, an increase this year of $7.18 per share, and an increase next year of $0.57 per share.

Biomarin Pharmaceutical Earnings Growth & BMRN Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.27 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.23 per share, and an increase next year of $0.90 per share.

Blueprint Medicines Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Biomarin Pharmaceutical Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):